Page last updated: 2024-08-17

cordycepin and Glioblastoma

cordycepin has been researched along with Glioblastoma in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Chen, J; Liang, RS; Liu, S; Wang, CH; Zhang, Q; Zhuang, BB; Zhuang, YD1
Chen, J; Shi, SS; Zhang, GL; Zhang, Q; Zheng, SX; Zhuang, BB1
Chaicharoenaudomrung, N; Jaroonwitchawan, T; Noisa, P1
Bai, Y; Bi, Y; Chen, Y; Li, H; Song, Y; Sun, Y; Yi, D; Zhao, G; Zhong, S1
Chaicharoenaudomrung, N; Heebkaew, N; Kunhorm, P; Noisa, P; Promjantuek, W; Rujanapun, N1
Baik, JS; Kim, CH; Kim, DH; Kim, KS; Lee, YC; Mun, SW; Park, MK; Park, SJ; Yoon, HK1
Chen, Y; Cheng, YC; Hsieh, CH; Hueng, DY; Tsai, WC1

Other Studies

7 other study(ies) available for cordycepin and Glioblastoma

ArticleYear
Exploring the mechanism of cordycepin combined with doxorubicin in treating glioblastoma based on network pharmacology and biological verification.
    PeerJ, 2022, Volume: 10

    Topics: Cell Line, Tumor; Doxorubicin; Glioblastoma; Humans; Network Pharmacology; Transcription Factors

2022
Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating MYC.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:17

    Topics: Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Drug Combinations; Glioblastoma; Humans; MicroRNAs; Myeloid Cell Leukemia Sequence 1 Protein; Phosphatidylinositol 3-Kinases; Proteoglycans; Proto-Oncogene Proteins c-akt; RNA-Binding Proteins; Temozolomide

2023
Cordycepin induces apoptotic cell death of human brain cancer through the modulation of autophagy.
    Toxicology in vitro : an international journal published in association with BIBRA, 2018, Volume: 46

    Topics: Apoptosis; Autophagy; Brain Neoplasms; Cells, Cultured; Deoxyadenosines; Glioblastoma; Humans; Molecular Structure; Neuroblastoma; Neurons; Reactive Oxygen Species

2018
Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Molecular pharmaceutics, 2018, 11-05, Volume: 15, Issue:11

    Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Deoxyadenosines; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Humans; Male; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Temozolomide; Treatment Outcome; Xenograft Model Antitumor Assays

2018
Fabrication of 3D calcium-alginate scaffolds for human glioblastoma modeling and anticancer drug response evaluation.
    Journal of cellular physiology, 2019, Volume: 234, Issue:11

    Topics: Alginates; Antineoplastic Agents; Calcium; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Deoxyadenosines; Doxorubicin; Glioblastoma; Humans; Neoplastic Stem Cells; Tissue Scaffolds; Vascular Endothelial Growth Factor A

2019
Apoptotic Effects of Cordycepin Through the Extrinsic Pathway and p38 MAPK Activation in Human Glioblastoma U87MG Cells.
    Journal of microbiology and biotechnology, 2016, Volume: 26, Issue:2

    Topics: Antifungal Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 8; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyadenosines; Fas Ligand Protein; Glioblastoma; Humans; p38 Mitogen-Activated Protein Kinases; Signal Transduction

2016
Cordycepin inhibits migration of human glioblastoma cells by affecting lysosomal degradation and protein phosphatase activation.
    The Journal of nutritional biochemistry, 2017, Volume: 41

    Topics: Ammonium Chloride; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Deoxyadenosines; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Lysosomes; Marine Toxins; Mice, Nude; Neoplasm Proteins; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Proteolysis; Tumor Burden; Xenograft Model Antitumor Assays

2017